Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 1:51pm ET
 +0.51 / +7.80%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 1.40. The median estimate represents a -21.99% decrease from the last price of 7.05.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -100.56%
Growthannually 13.67%


Growthquarterly -51.27%
Growthannually 19.41%
Key to the earnings and sales forecast charts.